EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of FGF Receptor-2rs2981578 SNP with breast cancer in women at the University of Gondar Comprehensive Specialized Hospital, Ethiopia

Mihiret Bogale, Tiget Ayelgn Mengstie iD, Ephrem Tadesse, Tadesse Asmamaw Dejenie, Banchamlak Teferi, Melkamu Siferih iD, Mulualem Nibret Takle, Tseganesh Asefa, Gashaw Dessie iD, Winta Tesfaye, Endeshaw Asaye Kindie, Hiwot Tezera Endale und 3 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0327034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Mihiret Bogale und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, School of Medicine, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia. Hauptthemen laut MEDLINE: Breast Neoplasms, Polymorphism, Single Nucleotide, Receptor, Fibroblast Growth Factor, Type 2. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Fibroblast Growth Factor Receptor-2 single nucleotide polymorphisms are implicated in breast cancer development. However, there are inconsistencies and contradictions in the reports. The current study aimed to determine the association between Fibroblast Growth Factor Receptor-2 rs2981578 single nucleotide polymorphism and breast cancer among female breast cancer patients.

Methods

A case-control study was conducted between August 2023 and April 2024 at University of Gondar Comprehensive Specialized Hospital, Gondar, and Northwest Ethiopia. Semi-structured was adapted to collect socio-demographic character and anthropometric measurement and 5 ml of blood were drawn from each randomly selected participant for molecular analysis. The data was entered into Epi-Data-7.2 and exported to SPSS-25. Binary logistic regression model was used to look into the association between various factors. Statistical significance was regarded as a p-value of < 0.05.

Results

The Fibroblast Growth Factor Receptor-2 Single Nucleotide Polymorphisms rs2981578 AA genotype and A allele were more frequent in breast cancer patients than in controls (37% vs. 17% and 58% vs 42%; the chi-square p = 0.025 and p = 0.009, respectively). Individuals with the AA genotype and A allele were more prone to breast cancer (OR = 3.3; 95% CI: 1.293–8.538, and OR =1.88; 95% CI: 1.173, 3.029, respectively) than those with the wild type GG genotype. The risk allele correlated with the late TNM stage (COR = 3.41, 95% CI: 1.07–10.88).

Conclusion

The AA genotype and the A allele of the Fibroblast Growth Factor Receptor-2 Single Nucleotide Polymorphisms rs2981578 gene are more prevalent among women with breast cancer. They are correlated with increased susceptibility to breast cancer and a worsening of its stage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsPolymorphism, Single NucleotideReceptor, Fibroblast Growth Factor, Type 2HumansFemaleEthiopiaMiddle AgedCase-Control StudiesAdultGenetic Predisposition to DiseaseGenotypeAllelesHospitals, SpecialAged

Substanzen

Receptor, Fibroblast Growth Factor, Type 2FGFR2 protein, human

Autor:innen und Institutionen

  • Department of Biomedical Sciences, School of Medicine, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.
  • Department of Biochemistry, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
  • Internal Medicine, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
  • Department of Clinical Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
  • Department of Obstetrics and Gynecology, School of Medicine, Debre Markos University, Debre Markos, Ethiopia.
  • Department of Medical Nursing, School of Nursing, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

ORCID-Profile: Tiget Ayelgn Mengstie, Melkamu Siferih, Gashaw Dessie

Zitieren

APA

Bogale, M., Mengstie, T. A., Tadesse, E., Dejenie, T. A., Teferi, B., Siferih, M., Takle, M. N., Asefa, T., Dessie, G., Tesfaye, W., Kindie, E. A., Endale, H. T., Tesfa, K. H., Ayelign, B., & Shibabaw, T. (2025). Association of FGF Receptor-2rs2981578 SNP with breast cancer in women at the University of Gondar Comprehensive Specialized Hospital, Ethiopia. PLOS One. https://doi.org/10.1371/journal.pone.0327034

Vancouver

Bogale M, Mengstie TA, Tadesse E, Dejenie TA, Teferi B, Siferih M, et al. Association of FGF Receptor-2rs2981578 SNP with breast cancer in women at the University of Gondar Comprehensive Specialized Hospital, Ethiopia. PLOS One. 2025. doi:10.1371/journal.pone.0327034

BibTeX
@article{Bogale2025,
  author = {Bogale, Mihiret and Mengstie, Tiget Ayelgn and Tadesse, Ephrem and Dejenie, Tadesse Asmamaw and Teferi, Banchamlak and Siferih, Melkamu and Takle, Mulualem Nibret and Asefa, Tseganesh and Dessie, Gashaw and Tesfaye, Winta and Kindie, Endeshaw Asaye and Endale, Hiwot Tezera and Tesfa, Kibur Hunie and Ayelign, Birhanu and Shibabaw, Tewodros},
  title = {Association of FGF Receptor-2rs2981578 SNP with breast cancer in women at the University of Gondar Comprehensive Specialized Hospital, Ethiopia},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0327034}
}
Kostenlos starten →